NCT00584714
Terminated
N/A
Long-Term Follow-Up of Selected Patients Enrolled in Phase 3 Clinical Trial 127-014 Using PB127 Ultrasound Imaging Agent
Point Biomedical39 sites in 1 country300 target enrollmentOctober 2007
ConditionsCoronary Artery Disease
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Coronary Artery Disease
- Sponsor
- Point Biomedical
- Enrollment
- 300
- Locations
- 39
- Primary Endpoint
- To collect longer-term follow-up clinical information on selected patients enrolled in Protocol 127-014
- Status
- Terminated
- Last Updated
- 17 years ago
Overview
Brief Summary
The purpose of this study is to collect longer term follow-up information concerning health and survival on selected patients who received PB127 for injectable suspension in the pivotal trial (127-014).
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients enrolled in Protocol 127-014 who
- •Were enrolled in Stratum 1
- •Did not undergo angiography during study evaluation
- •Did not have a clinical oucome during the initial 6 month follow-up period as described in Protocol 127-014.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
To collect longer-term follow-up clinical information on selected patients enrolled in Protocol 127-014
Time Frame: 1 year
Study Sites (39)
Loading locations...
Similar Trials
Recruiting
N/A
Long-term Follow-up of Study Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product in an Imugene Ltd. Clinical StudyParticipants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product (PBCAR) in a Precision BioSciences, Inc., Clinical StudyNCT05822427Imugene Limited75
Enrolling by Invitation
N/A
A Long Term Follow-Up Study for Subjects Who Have Received Q-CellsTransverse MyelitisNCT06163508University of Texas Southwestern Medical Center9
Completed
N/A
Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550Arthritis, RheumatoidNCT00414661Pfizer162
Completed
N/A
Long-term Data Collection for Subjects in MDX-010 StudiesMetastatic MelanomaNCT00928031Bristol-Myers Squibb160
Completed
N/A
A Follow up Study of Patients Treated With Imlifidase Prior to Kidney TransplantationKidney Transplant Failure and RejectionNCT03611621Hansa Biopharma AB31